Deficiencies in the transfer and availability of clinical trials evidence: A review of existing systems and standards

BMC Medical Informatics and Decision Making

Volumn 12, Issue 1, 2012, Pages

  Valkenhoef, Gert Van ^a,b   Tervonen, Tommi ^c   Brock, Bert De ^b   Hillege, Hans ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL (TOPIC); DECISION MAKING; DRUG DATABASE; EVIDENCE BASED MEDICINE; HUMAN; INFORMATION DISSEMINATION; MANAGEMENT; REGISTER; REVIEW;

CLINICAL TRIALS AS TOPIC; DATABASES, PHARMACEUTICAL; DECISION MAKING; EVIDENCE-BASED MEDICINE; HUMANS; INFORMATION DISSEMINATION; POLICY MAKING; REGISTRIES;

MLCS; MLOWN;

EID: 84865650376     PISSN: None     EISSN: 14726947     Source Type: Journal    
DOI: 10.1186/1472-6947-12-95     Document Type: Article

References (61)

1. The lethal consequences of failing to make use of all relevant evidence about the effects of medical treatments: the need for systematic reviews. Chalmers I, Treating individuals: from randomised trials to personalised medicine Edinburgh: Elsevier, Rothwell P, 2007 37 58
2. Evidence based medicine: what it is and what it isn't. Sackett DL, Rosenberg WMC, Gray JAM, Haynes RB, Richardson WS, BMJ 1996 312 7023 71 72 10.1136/bmj.312.7023.71 8555924
3. Rationale for systematic reviews. Mulrow CD, BMJ 1994 309 6954 597 599 10.1136/bmj.309.6954.597 8086953
4. Evidence synthesis as the key to more coherent and efficient research. Sutton AJ, Cooper NJ, Jones DR, 2009 9 29 publication
5. Clinical trial technology: at the inflection point. Bleicher P, Biosilico 2003 1 5 163 168 10.1016/S1478-5382(03)02373-4
6. The Use of Electronic Data Capture Tools in Clinical Trials: Web-Survey of 259 Canadian Trials. El Emam K, Jonker E, Sampson M, Krleza-Jeric K, Neisa A, J Med Internet Res 2009 11 8 10.2196/jmir.1120 19275984
7. Clinical trials evidence in drug development and regulation: a survey of existing systems and standards. van Valkenhoef G, Tervonen T, de Brock B, Hillege H, SOM Research Report 12003-Other, School of Management, Faculty of Economics and Business, University of Groningen, Groningen, The Netherlands 2012, [ http://irs.ub.rug.nl/dbi/4fcf224db9977 ]
8. Which resources should be used to identify RCT/CCTs for systematic reviews: a systematic review. Crumley ET, Wiebe N, Cramer K, Klassen TP, Hartling L, BMC Med Res Methodol 2005 5 24 10.1186/1471-2288-5-24 16092960
9. Mixed treatment comparison analysis provides internally coherent treatment effect estimates based on overviews of reviews and can reveal inconsistency. Caldwell DM, Welton NJ, Ades AE, J Clin Epidemiol 2010 63 8 875 882 10.1016/j.jclinepi.2009.08.025 20080027
10. Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses. Ioannidis JPA, Can Med Assoc J 2009 181 8 488 493 10.1503/cmaj.081086
11. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup DF, JAMA 1996 276 8 637 639 10.1001/jama.1996.03540080059030 8773637
12. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Schulz KF, Altman DG, Moher D, for the CONSORT group, PLoS Med 2010 7 3 1000251 10.1371/journal.pmed.1000251 20352064
13. Epidemiology and reporting of randomised trials published in PubMed journals. Chan AW, Altman DG, Lancet 2005 365 9465 1159 1162 10.1016/S0140-6736(05)71879-1 15794971
14. Empirical evidence for selective reporting of outcomes in randomized trials: Comparison of protocols to published articles. Chan A, Hrobjarttson A, Haahr M, Gotzsche P, Altman D, J Am Med Assoc 2004 291 20 2457 2465 10.1001/jama.291.20.2457
15. Electronic Trial Banks: A complementary method for reporting randomized trials. Sim I, Owens DK, Lavori PW, Rennels GD, Med Decis Making 2000 20 4 440 450 10.1177/0272989X0002000408 11059477
16. Optimal search strategies for retrieving scientifically strong studies of treatment from Medline: analytical survey. Haynes RB, McKibbon KA, Wilczynski NL, Walter SD, Werre SR, BMJ 2005 330 7501 1179 10.1136/bmj.38446.498542.8F 15894554
17. Combining classifiers for robust PICO element detection. Boudin F, Nie JY, Bartlett JC, Grad R, Pluye P, Dawes M, BMC Med Inform Decis Mak 2010 10 29 10.1186/1472-6947-10-29 20470429
18. Boolean versus ranked querying for biomedical systematic reviews. Karimi S, Pohl S, Scholer F, Cavedon L, Zobel J, BMC Med Inform Decis Mak 2010 10 58 10.1186/1472-6947-10-58 20937152
19. Development of the Cochrane Collaboration's central register of controlled clinical trials. Dickersin K, Manheimer E, Wieland S, Robinson KA, Lefebvre C, McDonald S, Eval Health Prof 2002 25 38 38 64 11868444
20. About The Cochrane Library,. The Cochrane Foundation, 2010 [ http://www.thecochranelibrary.com/view/0/AboutTheCochraneLibrary.html ]. [ Archived at http://www.webcitation.org/5tEEbQuNz ]
21. Registering clinical trials. Dickersin K, Rennie D, J Am Med Inform Assoc 2003 290 4 516 523
22. Publication of Clinical Trials Supporting Successful New Drug Applications: A Literature Analysis. Lee K, Bacchetti P, Sim I, PLoS Med 2008 5 9 191 10.1371/journal.pmed.0050191 18816163
23. Publication bias-the case for an international registry of clinical-trials. Simes RJ, J Clin Oncol 1986 4 10 1529 1541 3760920
24. Trial Banks: An Informatics Foundation for Evidence-Based Medicine. Sim I, PhD thesis, Stanford University: Stanford, CA, USA 1997
25. An ontology of randomized controlled trials for evidence-based practice: content specification and evaluation using the competency decomposition method. Sim I, Olasov B, Carini S, J Biomed Inform 2004 37 2 108 119 10.1016/j.jbi.2004.03.001 15120657
26. Beyond trial registration: A global trial bank for clinical trial reporting. Sim I, Detmer D, PLoS Med 2005 2 11 1090 1092
27. AMIA Global Trial Bank. AMIA, 2010, [ https://www.amia.org/global-trial- bank ]. [ Archived at, http://www.webcitation.org/5ma1fjB1A ]
28. Design and implementation of a national clinical trials registry. McCray AT, Ide NC, JAMIA 2000 7 3 313 323 10833169
29. Issues in the registration of clinical trials. Zarin DA, Ide NC, Tse T, Harlan WR, West JC, Lindberg DAB, JAMA 2007 297 19 2112 2120 10.1001/jama.297.19.2112 17507347
30. Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1). Krleza-Jeric K, Chan AW, Dickersin K, Sim I, Grimshaw J, Gluud C, the Ottawa Group, BMJ 2005 330 7497 956 958 10.1136/bmj.330.7497.956 15845980
31. Clinical trial registration: transparency is the watchword. Sim I, Chan AW, Gulmezoglu AM, Evans T, Pang T, Lancet 2006 367 9523 1631 1633 10.1016/S0140-6736(06)68708-4 16714166
32. Making Clinical Data Widely Available. Kaiser J, Science 2008 322 5899 217 218 10.1126/science.322.5899.217 18845745
33. Reporting the findings of clinical trials: a discussion paper. Ghersi D, Clarke M, Berlin J, Guelmezoglu AM, Kush R, Lumbiganon P, Moher D, Rockhold F, Sim I, Wager E, Bull of the World Health Organization 2008 86 6 492 493
34. Medicine-Moving toward transparency of clinical trials. Zarin DA, Tse T, Science 2008 319 5868 1340 1342 10.1126/science.1153632 18323436
35. Bias, Spin, and Misreporting: Time for Full Access to Trial Protocols and Results. Chan AW, PLoS Med 2008 5 11 230 10.1371/journal.pmed.0050230 19067481
36. Keeping Raw Data in Context. Sim I, Chute CG, Lehmann H, Nagarajan R, Nahm M, Scheuermann RH, Science 2009 323 5915 713a 10.1126/science.323.5915.713a
37. Food and Drug Administration Amendments Act of 2007,. FDA, Public Law 110-85 (September 27, 2007), Section 801 [From the U.S. Government Printing Office]
38. Progress and Deficiencies in the Registration of Clinical Trials. Wood AJJ, N Engl J Med 2009 360 8 824 830 10.1056/NEJMsr0806582 19228628
39. About Trial Registration: Organizations with Policies. ICTRP, 2010, [ http://www.who.int/ictrp/trial-reg/en/index2.html ]. [ Archived at http://www.webcitation.org/5mZpckdBf ]
40. Reporting "Basic Results" in ClinicalTrials.gov. Tse T, Williams RJ, Zarin DA, Chest 2009 136 295 303 10.1378/chest.08-3022 19584212
41. ClinicalTrials.gov Protocol Data Element Definitions (DRAFT). ClinicalTrialsgov, 2009, [ http://prsinfo.clinicaltrials.gov/definitions.html ]. [ Archived at http://www.webcitation.org/5mYe6OxvP ]
42. ClinicalTrials.gov "Basic Results" Data Element Definitions (DRAFT). ClinicalTrialsgov, 2009, [ http://prsinfo.clinicaltrials.gov/results- definitions.html ]
43. Linking to ClinicalTrials.gov. ClinicalTrialsgov, 2011, [ http://clinicaltrials.gov/ct2/info/linking ]. [ Archived at http://www. webcitation.org/66HHPj8RI ]
44. About EU Clinical Trials Register. European Medicines Agency, 2011, [ https://www.clinicaltrialsregister.eu/about.html ]. [ Archived at http://www.webcitation.org/5yNkGPZZX ]
45. EU Clinical Trials Register. European Medicines Agency (EMA), 2012, [ https://www.clinicaltrialsregister.eu/ ]. [ Archived at http://www.webcitation. org/66HHLkoV1 ]
46. EudraCT Public Web Report for February 2011. European Medicines Agency, 2011, [ https://eudract.ema.europa.eu/docs/statistics/EudraCT-Statistics- February.pdf ]
47. Current Controlled Trials: Frequently asked questions. Current Controlled Trials Ltd, 2010, [ http://www.controlled-trials.com/information/faqs ]. [ Archived at http://www.webcitation.org/5mbV14caj ]
48. The Mexico statement on health research. The Ministerial summit on health research, 2004, [ http://www.who.int/rpc/summit/agenda/en/mexico-statement-on- health-research.pdf ]. [Mexico City, November 16-20]
49. National and multinational prospective trial registers. Grobler L, Siegfried N, Askie L, Hooft L, Tharyan P, Antes G, Lancet 2008 372 9645 1201 1202 10.1016/S0140-6736(08)61498-1 19094940
50. Systematic Reviews and Meta-Analyses in the New Age of Transparency. Honig PK, Clin Pharmacol Ther 2010 88 2 155 158 10.1038/clpt.2010.124 20648031
51. The evolution of The Cochrane Library, 1988-2003. Starr M, Chalmers I, 2003, [ http://www.update-software.com/history/clibhist.htm. ]
52. New drug approval success rate in Europe in 2009. Eichler HG, Aronsson B, Abadie E, Salmonson T, Nat Rev Drug Discov 2010 9 355 356 10.1038/nrd3169 20431561
53. A practical method for transforming free-text eligibility criteria into computable criteria. Tu SW, Peleg M, Carini S, Bobak M, Ross J, Rubin D, Sim I, J Biomed Inform 2011 44 2 239 250 10.1016/j.jbi.2010.09.007 20851207
54. Biomedical Research Integrated Domain Group (BRIDG), BRIDG Model Release 3.0.3 User's Guide 2010, [ http://gforge.nci.nih.gov/frs/?group-id=342 ]
55. The Human Studies Database Project: Federating Human Studies Design Data Using the Ontology of Clinical Research. Sim I, Carini S, Tu S, Wynden R, BH P, Mollah S, Gabriel D, Hagler H, Scheuermann R, Lehmann H, Wittkowski K, Nahm M, Bakken S, Proceedings of the AMIA CRI Summit 2010 AMIA, 2010. http://proceedings.amia.org/
56. Development and evaluation of a study design typology for human research. Carini S, Pollock BH, Lehmann HP, Bakken S, Barbour EM, Gabriel D, Hagler HK, Harper CR, Mollah SA, Nahm M, Nguyen HH, Scheuermann RH, Sim I, AMIA Annu Symp Proc 2009 2009 81 85 20351827
57. Toward an ontology-based framework for clinical research databases. Kong YM, Dahlke C, Xiang Q, Qian Y, Karp D, Scheuermann RH, J Biomed Inform 2011 44 48 58 10.1016/j.jbi.2010.05.001 20460173
58. Ontology-Based eXtensible Data Model. Scheuermann RH, 2010, [ http://pathcuric1.swmed.edu/Research/scheuermann/OBX.html ]. [ Archived at http://www.webcitation.org/5y3tihqvB ]
59. Review paper: coding systems in health care. Cimino JJ, Methods Inf Med 1996 35 4-5 273 284 9019091
60. Determining correspondences between high-frequency MedDRA concepts and SNOMED: a case study. Nadkarni PM, Darer JD, BMC Med Inform Decis Mak 2010 10 66 10.1186/1472-6947-10-66 21029418
61. Mapping the categories of the Swedish primary health care version of ICD-10 to SNOMED CT concepts: rule development and intercoder reliability in a mapping trial. Vikstrom A, Skaner Y, Strender LE, Nilsson GH, BMC Med Inform Decis Mak 2007 7 9 10.1186/1472-6947-7-9 17472757